MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation expense
Prepaid expenses and other asset...
Non-cash lease expense
Depreciation and amortization
Negative Cash Flow Breakdown
Accounts payable and accrued lia...
Operating lease liability
Proceeds from issuance of common...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-8,581
-24,199
19,356
-7,729
Depreciation and amortization
8
8
36
32
Non-cash lease expense
346
338
331
322
Stock-based compensation expense
569
575
795
924
Non-cash activity related to the sale of future royalties
0
0
316
41
Issuance costs associated with warrant liabilities
0
1,406
-
-
Gain on release of liability related to sale of future royalties associated with sale of assets
-
-
27,189
-
Amortization of premiums and discounts on investments
-
-
0
0
Change in fair value of warrant liabilities
-1,297
12,757
-
-
Accounts receivable
0
0
1,138
491
Prepaid expenses and other assets
-434
126
-75
-643
Accounts payable and accrued liabilities
-832
521
1,397
1,030
Operating lease liability
-293
-281
-350
-341
Total adjustments
-1,065
15,198
-25,727
2,160
Net cash used in operating activities
-9,646
-9,001
-6,371
-5,569
Purchases of investments
-
-
0
0
Sales and maturities of investments
-
-
0
0
Proceeds from the sale of erivedge
-
-
2,500
-
Net cash provided by investing activities
0
0
2,500
0
Proceeds from issuance of common stock, preferred stock, pre-funded warrants, and common warrants, net of issuance costs
-282
18,941
-119
6,049
Payment of liability of future royalties, net of imputed interest
0
0
0
1,567
Net cash provided by financing activities
-282
18,941
-119
4,482
Net increase (decrease) in cash and cash equivalents and restricted cash
-9,928
9,940
-3,990
-1,087
Cash and cash equivalents and restricted cash, beginning of period
15,545
5,605
9,595
20,541
Cash and cash equivalents and restricted cash, end of period
5,617
-
-
-
Reclassification of january 2026 series a common warrants and january 2026 series c common warrants liability to equity
28,599
-
-
-
Conversion of preferred stock to common stock and pre-funded warrants upon shareholder approval, net of issuance costs
2,261
-
-
-
Issuance costs in accounts payable and accrued expenses
56
-
-
-
Cash paid for interest
0
-
-
-
Cash and cash equivalents
5,073
-
-
-
Restricted cash
544
-
-
-
Total cash, cash equivalents and restricted cash shown in the statement of cash flows
5,617
15,545
5,605
9,595
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash and cash...
-$9,928K
(-0.70%↓ Y/Y)
Net cash used in
operating activities
-$9,646K
(36.79%↑ Y/Y)
Net cash provided by
financing activities
-$282K
(-105.22%↓ Y/Y)
Stock-based compensation
expense
$569K
(-75.25%↓ Y/Y)
Prepaid expenses and
other assets
-$434K
(49.18%↑ Y/Y)
Non-cash lease expense
$346K
(-44.19%↓ Y/Y)
Depreciation and
amortization
$8K
(-92.08%↓ Y/Y)
Net loss
-$8,581K
(55.33%↑ Y/Y)
Total adjustments
-$1,065K
(-126.98%↓ Y/Y)
Proceeds from issuance of
common stock,...
-$282K
(-102.99%↓ Y/Y)
Canceled cashflow
$1,357K
Change in fair value of
warrant liabilities
-$1,297K
Accounts payable and
accrued liabilities
-$832K
(-799.16%↓ Y/Y)
Operating lease liability
-$293K
(54.57%↑ Y/Y)
Buy us a coffee
CURIS INC (CRIS)
CURIS INC (CRIS)